At the recent 2013 European Association for the Study of Diabetes (EASD) conference, Abbott debuted a new diabetes technology category called Flash Glucose Monitoring...

Downloading data, CGMs and insurance coverage, and how the Mediterranean diet is good for your heart.

An open letter to the FDA’s Dr. Margaret Hamburg from diaTribe .

On March 3, AstraZeneca announced FDA approval for the Bydureon dual-chambered pen (once-weekly exenatide) to improve glycemic control in people with type 2. The device...

On May 31 and June 17, MannKind announced that it had completed its new phase 3 clinical studies of Afrezza for people with type 1 and 2 diabetes. As a reminder, Afrezza...

On October 14, Cellnovo announced the start of a usability study of its mobile-enabled insulin pump in the UK. The trial will essentially study how patients like using...

On November 25, the FDA announced the removal of the major restrictions on the prescription and use of GlaxoSmithKline’s Avandia (rosiglitazone) for type 2 diabetes...

The three top trends we saw in diabetes in 2013.

In a live online chat on March 31, highly-regarded FDA Director Dr. Courtney Lias and patient advocate Bennet Dunlap, founder of Strip Safely discussed the new blood...

In May 2013, Jawbone announced the acquisition of BodyMedia and the launch of a new app platform for its UP health wristband , which tracks movement and sleep and syncs...

Inspiring non-profit Insulindependence recently launched a member search feature that allows users to search for other people with diabetes in their area with similar...

(S)he said what!?

On April 16, Vivus announced that the FDA approved a change to the distribution of Qsymia . Qsymia is a weight loss and weight management drug that is designed to be...

On August 23, the American Association of Clinical Endocrinologists (AACE) announced that it will hold a consensus conference on obesity called “Building an Evidence...

(S)he said what!?

Are all carbs created equal? Adam learns why 30 grams of carbs is NOT always 30 grams of carbs…

On January 27, Asante and Tidepool announced an insulin pump data downloading partnership for the Snap insulin pump . The agreement marks the first diabetes device...

StripSafely is a new advocacy campaign that encourages people with diabetes and caregivers to write Congress and push the FDA on an important issue: glucose test strip...

On October 3, Orexigen announced that it submitted Contrave (naltrexone/bupropion) to the European Medicine Agency for weight loss management. Assuming a successful...

On December 27, Takeda announced that it would stop development of TAK-875 (fasiglifam) due to liver safety concerns – this was one of the most unfortunate announcements...